Showing results (41-50 of 114) with videos related to
Sort By:
Pageof 12
Inflammatory Bowel Diseases|March 9, 2007
Infliximab and the risk of latent viruses reactivation in active Crohn's diseaseAlessandro Lavagna, Massimiliano Bergallo, Marco Daperno, et al.Scandinavian Journal of Gastroenterology|January 17, 2009
Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: proposal of an ultrasonographic scoreCaterina Rigazio, Elena Ercole, Cristiana Laudi, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 4, 2018
Ustekinumab in the management of Crohn's disease: Expert opinionAlessandro Armuzzi, Sandro Ardizzone, Livia Biancone, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 26, 2023
A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologicsLuca Degli Esposti, Marco Daperno, Melania Dovizio, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2023
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensusSandro Ardizzone, Alessandro Armuzzi, Flavio Caprioli, et al.Scandinavian Journal of Gastroenterology|September 23, 2022
Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platformMichela Mangia, Enrica Giuffrida, Valeria Figini, et al.Techniques in Coloproctology|October 7, 2020
Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists GroupG Leoncini, F Donato, L Reggiani-Bonetti, et al.Expert Opinion on Biological Therapy|July 15, 2020
Ustekinumab for treating ulcerative colitis: an expert opinionLivia Biancone, Sandro Ardizzone, Alessandro Armuzzi, et al.Techniques in Coloproctology|June 1, 2022
Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicabilityA Caputo, P Parente, M Cadei, et al.Journal of Clinical Medicine|April 12, 2022
Has the Removing of the Mesentery during Ileo-Colic Resection an Impact on Post-Operative Complications and Recurrence in Crohn's Disease? Results from the Resection of the Mesentery Study (Remedy)Michela Mineccia, Giovanni Maconi, Marco Daperno, et al.Pageof 12